CMI’Nov Minimally invasive ANNULOPLASTY for the treatment of MITRAL REGURGITATION Mitral Regurgitation Mitral regurgitation is one of the most frequent, hard to treat and deadly chronic condition associated with heart failure. READ MORE Product Mit’rep: an opportunity to offer valve repair to many patients currently ineligible for minimally invasive treatments. READ MORE LATEST NEWS Posted on November 25, 2020November 25, 2020 CMI’nov is honoured by BUSI incubator ... Tags Monistrol-sur-LoirePosted on June 2, 2020June 30, 2020 CMI’nov expands its leadership team with the appointment of Laure Oliver as Director Regulatory Affairs. CMI’nov today announced that Laure Oliver will join its leadership team as Director Regulatory Affairs. Tags Monistrol-sur-LoirePosted on May 25, 2020June 30, 2020 CMI’nov further expands its leadership team, naming Denis Henrard Chief Business Officer. CMI’nov is pleased to announce that Denis Henrard has joined its leadership team as Chief Business Officer. VIEW ALL POSTS
Tags Monistrol-sur-LoirePosted on June 2, 2020June 30, 2020 CMI’nov expands its leadership team with the appointment of Laure Oliver as Director Regulatory Affairs. CMI’nov today announced that Laure Oliver will join its leadership team as Director Regulatory Affairs.
Tags Monistrol-sur-LoirePosted on May 25, 2020June 30, 2020 CMI’nov further expands its leadership team, naming Denis Henrard Chief Business Officer. CMI’nov is pleased to announce that Denis Henrard has joined its leadership team as Chief Business Officer.